269 related articles for article (PubMed ID: 28413575)
1. The Role of Estrogen in Cardiac Metabolism and Diastolic Function.
Li S; Gupte AA
Methodist Debakey Cardiovasc J; 2017; 13(1):4-8. PubMed ID: 28413575
[TBL] [Abstract][Full Text] [Related]
2. Is Cardiac Diastolic Dysfunction a Part of Post-Menopausal Syndrome?
Maslov PZ; Kim JK; Argulian E; Ahmadi A; Narula N; Singh M; Bax J; Narula J
JACC Heart Fail; 2019 Mar; 7(3):192-203. PubMed ID: 30819374
[TBL] [Abstract][Full Text] [Related]
3. Myocardial reverse remodeling: how far can we rewind?
Rodrigues PG; Leite-Moreira AF; Falcão-Pires I
Am J Physiol Heart Circ Physiol; 2016 Jun; 310(11):H1402-22. PubMed ID: 26993225
[TBL] [Abstract][Full Text] [Related]
4. Dual Endothelin-A/Endothelin-B Receptor Blockade and Cardiac Remodeling in Heart Failure With Preserved Ejection Fraction.
Valero-Munoz M; Li S; Wilson RM; Boldbaatar B; Iglarz M; Sam F
Circ Heart Fail; 2016 Nov; 9(11):. PubMed ID: 27810862
[TBL] [Abstract][Full Text] [Related]
5. Role of estrogen in diastolic dysfunction.
Zhao Z; Wang H; Jessup JA; Lindsey SH; Chappell MC; Groban L
Am J Physiol Heart Circ Physiol; 2014 Mar; 306(5):H628-40. PubMed ID: 24414072
[TBL] [Abstract][Full Text] [Related]
6. GLP-1 Improves Diastolic Function and Survival in Heart Failure with Preserved Ejection Fraction.
Nguyen TD; Shingu Y; Amorim PA; Schenkl C; Schwarzer M; Doenst T
J Cardiovasc Transl Res; 2018 Jun; 11(3):259-267. PubMed ID: 29464655
[TBL] [Abstract][Full Text] [Related]
7. Prevalence and correlates of left ventricular diastolic dysfunction and heart failure with preserved ejection fraction in elderly community residents.
Cui X; Zhou J; Jin X; Zhou J; Fu M; Hu K; Sun A; Ge J
Int J Cardiol; 2017 Jan; 227():820-825. PubMed ID: 27836303
[TBL] [Abstract][Full Text] [Related]
8. A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation.
Paulus WJ; Tschöpe C
J Am Coll Cardiol; 2013 Jul; 62(4):263-71. PubMed ID: 23684677
[TBL] [Abstract][Full Text] [Related]
9. Why are women more likely than men to develop heart failure with preserved ejection fraction?
Scantlebury DC; Borlaug BA
Curr Opin Cardiol; 2011 Nov; 26(6):562-8. PubMed ID: 21993357
[TBL] [Abstract][Full Text] [Related]
10. Heart failure with preserved ejection fraction: refocusing on diastole.
Abbate A; Arena R; Abouzaki N; Van Tassell BW; Canada J; Shah K; Biondi-Zoccai G; Voelkel NF
Int J Cardiol; 2015 Jan; 179():430-40. PubMed ID: 25465302
[TBL] [Abstract][Full Text] [Related]
11. Functional iron deficiency and diastolic function in heart failure with preserved ejection fraction.
Kasner M; Aleksandrov AS; Westermann D; Lassner D; Gross M; von Haehling S; Anker SD; Schultheiss HP; Tschöpe C
Int J Cardiol; 2013 Oct; 168(5):4652-7. PubMed ID: 23968714
[TBL] [Abstract][Full Text] [Related]
12. Vascular extracellular vesicles in comorbidities of heart failure with preserved ejection fraction in men and women: The hidden players. A mini review.
Gohar A; de Kleijn DPV; Hoes AW; Rutten FH; Hilfiker-Kleiner D; Ferdinandy P; Sluijter JPG; den Ruijter HM
Vascul Pharmacol; 2018 Dec; 111():1-6. PubMed ID: 29807165
[TBL] [Abstract][Full Text] [Related]
13. Incidence of chronic heart failure with preserved left ventricular ejection fraction in patients with hypertension and isolated mild diastolic dysfunction.
Brzyżkiewicz H; Konduracka E; Gajos G; Janion M
Pol Arch Med Wewn; 2016; 126(1-2):12-8. PubMed ID: 26810565
[TBL] [Abstract][Full Text] [Related]
14. The differences in the relationship between diastolic dysfunction, selected biomarkers and collagen turn-over in heart failure patients with preserved and reduced ejection fraction.
Michalski B; Trzciński P; Kupczyńska K; Miśkowiec D; Pęczek Ł; Nawrot B; Lipiec P; Kasprzak JD
Cardiol J; 2017; 24(1):35-42. PubMed ID: 27748500
[TBL] [Abstract][Full Text] [Related]
15. Phosphorylation of cardiac Myosin-binding protein-C is a critical mediator of diastolic function.
Rosas PC; Liu Y; Abdalla MI; Thomas CM; Kidwell DT; Dusio GF; Mukhopadhyay D; Kumar R; Baker KM; Mitchell BM; Powers PA; Fitzsimons DP; Patel BG; Warren CM; Solaro RJ; Moss RL; Tong CW
Circ Heart Fail; 2015 May; 8(3):582-94. PubMed ID: 25740839
[TBL] [Abstract][Full Text] [Related]
16. [Heart failure with preserved left ventricular ejection fraction].
Maeder MT; Rickli H
Praxis (Bern 1994); 2013 Oct; 102(21):1299-307. PubMed ID: 24129298
[TBL] [Abstract][Full Text] [Related]
17. Ivabradine Ameliorates Cardiac Function in Heart Failure with Preserved and Reduced Ejection Fraction via Upregulation of miR-133a.
Shao S; Zhang Y; Gong M; Yang Q; Yuan M; Yuan M; Suo Y; Wang X; Li Y; Bao Q; Li G
Oxid Med Cell Longev; 2021; 2021():1257283. PubMed ID: 34630844
[TBL] [Abstract][Full Text] [Related]
18. Prevention of heart failure with preserved ejection fraction (HFpEF): reexamining microRNA-21 inhibition in the era of oligonucleotide-based therapeutics.
Ben-Nun D; Buja LM; Fuentes F
Cardiovasc Pathol; 2020; 49():107243. PubMed ID: 32629211
[TBL] [Abstract][Full Text] [Related]
19. Heart failure with preserved left ventricular ejection fraction: concepts, misconceptions and future directions.
Soma J
Blood Press; 2011 Jun; 20(3):129-33. PubMed ID: 21142436
[TBL] [Abstract][Full Text] [Related]
20. Heart Failure With Preserved Ejection Fraction Induces Beiging in Adipose Tissue.
Valero-Muñoz M; Li S; Wilson RM; Hulsmans M; Aprahamian T; Fuster JJ; Nahrendorf M; Scherer PE; Sam F
Circ Heart Fail; 2016 Jan; 9(1):e002724. PubMed ID: 26721917
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
